SURGICAL TREATMENT OF MULTIPLE LUNG METASTASIS IN PATIENT WITH SOFT ISSUE AND VISCERAL SARCOMAS

Introduction. The aim of this study was to analyze the surgical treatment for multiple intrapulmonary metastases sarcomas of bone and soft tissue. Methods. This analysis includes retrospective survival data from 24 patients with soft tissue sarcomas and bone sarcomas who were treated from January 2004 to December 2014 in MRRC and meet the following criteria: the presence of more than four lesions in the lungs, no progression of the primary tumor, no distant metastases and overall satisfactory status (ECOG 0–1). Survival of patients assessed by Kaplan-Meier method. results. In total 49 pulmonary metastasectomy were performed. There were no postoperative deaths. In 4 patients underwent repeated operations. From this cohort 1-year survival has survived 10 patients (41.6 %), 5-year – 3 (12.5 %). 3 patients are alive 28, 62 and 139 months after surgery with no evidence of progression of tumors. conclusion. The detection of lesion in the pulmonary parenchyma is most often regarded as the poor prognosis of the disease. Individually tailored treatment strategy allows you to increase the overall life expectancy and improve quality of life. The surgical method can be considered as a stage of complex treatment, as in the progression of the disease in the lungs, and in synchronous lesions. Surgical repeated resection may be an appropriate treatment for patients with progression and the justified possibility of an operation.

osteosarcoma, soft tissue sarcoma, multiple lung metastasis, pulmonary metastasectomy, lung resection, thoracic surgery

1. Pikin O.V. Abstract of the thesis of the doctor of medical sciences. M., 2006. 35 p. [in Russian]

2. Teplyakov V.V., Karpenko V.Yu., Bulanov A.A. Malignant tumors of the bone. Oncology. Clinical recommendations. M., 2009. P. 810–828. [in Russian]

3. Bhattasali O., Vo A.T., Roth M., Geller D., Randall RL., Gorlick R., Gill J. Variability in the reported management of pulmonary metastases in osteosarcoma // Cancer Med. 2015. Vol. 4 (4). P. 523–531. doi: 10.1002/cam4.407.

4. Dear R.F., Kelly P.J., Wright G.M., Stalley P., McCaughan B.C., Tattersall M.H. Pulmonary metastasectomy for bone and soft tissue sarcoma in Australia: 114 patients from 1978 to 2008 // Asia Pac. J. Clin. Oncol. 2012. Vol. 8 (3). P. 292–302. doi: 10.1111/j.1743-7563.2012.01521.x.

5. Internullo E., Cassivi S.D., Van Raemdonck D., Friedel G., Treasure T. ESTS Pulmonary Metastasectomy Working Group. Pulmonary metastasectomy: a survey of current practice amongst members of the European Society of Thoracic Surgeons // J. Thorac. Oncol. 2008. Vol. 3 (11). P. 1257–1266. doi: 10.1097/JTO.0b013e31818bd9da.

6. Kane J.M., Finley J.W., Driscoll D., Kraybill W.G., Gibbs J.F. The treatment and outcome of patients with soft tissue sarcomas and synchronous metastases // Sarcoma. 2002. Vol. 6 (2). P. 69–73.

7. Martini N., McCormack P.M. Evolution of the surgical management of pulmonary metastases // Chest Surg. Clin. North Am. 1998. Vol. 8 (1). P. 13–27.

8. Mizuno T., Taniguchi T., Ishikawa Y., Kawaguchi K., Fukui T., Ishiguro F., Nakamura S., Yokoi K. Pulmonary metastasectomy for osteogenic and soft tissue sarcoma: who really benefits from surgical treatment? // Eur. J. Cardiothorac. Surg. 2013. Vol. 43 (4). P. 795–799. doi: 10.1093/ejcts/ezs419.

9. Okiror L., Peleki A., Moffat D., Bille A., Bishay E., Rajesh P., Steyn R., Naidu B., Grimer R., Kalkat M. Survival following Pulmonary Metastasectomy for Sarcoma // Thorac. Cardiovasc Surg. 2015. [Epub ahead of print].

10. Pfannschmidt J., Egerer G., Bischof M., Thomas M., Dienemann H. Surgical intervention for pulmonary metastases // Dtsch. Arztebl. Int. 2012. Vol. 109 (40). P. 645–651. doi: 10.3238/arztebl.2012.0645.

11. Porter G.A., Cantor S.B., Walsh G.L., Rusch V.W., Leung D.H., DeJesus A.Y., Pollock R.E., Brennan M.F., Pisters P.W. Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue sarcoma: a combined analysis from the University of Texas M. D. Anderson and Memorial Sloan-Kettering Cancer Centers // J. Thorac. Cardiovasc. Surg. 2004. Vol. 127 (5). P. 1366–1372.

12. Schur S., Hoetzenecker K., Lamm W., Koestler WJ., Lang G., Amann G., Funovics P., Nemecek E., Noebauer I., Windhager R., Klepetko W., Brodowicz T. Pulmonary metastasectomy for soft tissue sarcoma-report from a dual institution experience at the Medical Univer- sity of Vienna // Eur. J. Cancer. 2014. Vol. 50 (13). P. 2289–2297. doi: 10.1016/j.ejca.2014.05.009.

13. Smith R., Demmy T.L. Pulmonary metastasectomy for soft tissue sarcoma // Surg. Oncol. Clin. North Am. 2012. Vol. 21 (2). P. 269–286. doi:10.1016/j.soc.2011.12.002.

14. Treasure T., Fiorentino F., Scarci M., Møller H., Utley M. Pulmonary metastasectomy for sarcoma: a systematic review of reported outcomes in the context of Thames Cancer Registry data // BMJ Open. 2012. Vol. 2 (5). pii: e001736. doi: 10.1136/bmjopen-2012-001736.